Target intelligence / Profile preview

Tyrosinase (Agaricus bisporus) (PPO)

Target
PPO
Molecular classification
Enzyme, Oxidoreductase, Copper-containing metalloenzyme, Type-3 copper protein
01

Overview

Mushroom tyrosinase, primarily isolated from the common button mushroom Agaricus bisporus, is a copper-containing enzyme that serves as a rate-limiting catalyst in the production of melanin (UniProt: P00431). It possesses two distinct catalytic activities: monophenolase activity, which hydroxylates L-tyrosine to L-DOPA, and diphenolase activity, which oxidizes L-DOPA to dopaquinone (PubMed: 25553383). Although it is a fungal enzyme, it is the most widely used biochemical model for studying human tyrosinase due to its high homology, commercial availability, and ease of purification. In the pharmaceutical and cosmetic industries, it is the primary target for developing skin-lightening agents and treatments for hyperpigmentation disorders such as melasma and solar lentigines (PubChem: Tyrosinase). Inhibitors of this enzyme, such as kojic acid and hydroquinone, are used to reduce melanin synthesis, though they must be monitored for safety concerns like skin irritation and potential cytotoxicity. Beyond medicine, mushroom tyrosinase is also a focus of the food industry, where its inhibition is sought to prevent the enzymatic browning of produce.

Other names
Mushroom tyrosinasePolyphenol oxidaseMonophenol monooxygenaseCatechol oxidaseMonophenol, L-dopa:oxygen oxidoreductase
02

Mechanism of action

Inhibition of the catalytic activity of tyrosinase, specifically blocking the hydroxylation of L-tyrosine (monophenolase activity) and the oxidation of L-DOPA to dopaquinone (diphenolase activity) to prevent melanin formation (PubMed: 29035199).

03

Biological functions

Melanin biosynthesisPigmentationBrowning reactionDefense responseOxidation of phenols
04

Disease associations

HyperpigmentationMelasmaLentigoPost-inflammatory hyperpigmentationMelanomaParkinson's disease (as a model for neuromelanin)
05

Safety considerations

Skin irritationContact dermatitisExogenous ochronosis (with hydroquinone)Chemical leukodermaPotential cytotoxicity to melanocytes
06

Interacting drugs

Kojic acid

8 more in the full profile.

07

Biomarkers

Melanin concentrationDOPAchrome formation rateL-DOPA levelsTyrosinase activity assay

Beyond the preview

Go deeper on Tyrosinase (Agaricus bisporus) (PPO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tyrosinase (Agaricus bisporus) (PPO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call